Skip to main content
Close Search
BIVDA NewsletterBIVDA NewsletterBIVDA Newsletter
search
Menu
  • Home
  • Consultations
  • Events Diary
  • Highlights Archive
  • Membership News Archive
  • Regulatory Newsletter
  • Tenders
  • Training
    • In-Person Events
    • Webinars
  • Funding Opportunities
  • Working Party News
    • Working Party Archive
      • AMR Taskforce Archive
      • Covid 19 Taskforce Archive
      • Digital Working Party Archive
      • Environmental Working Party Archive
      • European Affairs Archive
      • Export Working Party Archive
      • External Affairs Working Party
      • Genomics Working Party Archive
      • Market Dynamics Archive
      • Near Patient Testing Working Party Archive
      • Regulatory Affairs Working Party Archive
      • Infectious Diseases Working Party Archive
      • Procurement Working Party Archive
  • search
Tag

UK REACH: Information on evaluation activity in 2025 (Article 54 reporting)

UK REACH: Information on evaluation activity in 2025 (Article 54 reporting) Environmental NewsletterEnvironmental Newsletter ArchiveUK Government Updates Environmental NewsletterUK Government Updates Environmental Newsletter Archive

UK REACH: Information on evaluation activity in 2025 (Article 54 reporting)

Dear Members, relevant if you have to register substances under UK REACH. Information on evaluation activity in 2025 (Article 54 reporting) HSE has an obligation to report annually on the activity undertaken to evaluate registration dossiers and substances. This is described in Article 54 of UK REACH. The Article 54 report for 2025 can be found on HSE’s website. The…
Ben Kemp
Ben KempMarch 5, 2026
UK REACH: Information on evaluation activity in 2025 (Article 54 reporting) Environmental NewsletterEnvironmental Newsletter ArchiveUK Government Updates Environmental NewsletterUK Government Updates Environmental Newsletter Archive

UK REACH: Information on evaluation activity in 2025 (Article 54 reporting)

Information on evaluation activity in 2025 (Article 54 reporting) HSE has an obligation to report annually on the activity undertaken to evaluate registration dossiers and substances. This is described in Article 54 of UK REACH. The Article 54 report for 2025 can be found on HSE’s website. The report directs registrants to the consolidated Recommendations to registrants which aim to…
Ben Kemp
Ben KempMarch 5, 2026

Email us
membership@bivda.org.uk

Call us
+44 (0) 333 3208 823

Website
www.bivda.org.uk

Find us
299 Oxford Street (5th floor)
London, W1C 2DZ

© Copyright 2026 BIVDA Ltd is registered in England, with Company Number 2687137 Registered Office is 299 Oxford Street (5th floor), London, W1C 2DZ. VAT Number 563105858
Web Design by WDAT

  • twitter
  • linkedin
Close Menu
  • Home
  • Consultations
  • Events Diary
  • Highlights Archive
  • Membership News Archive
  • Regulatory Newsletter
  • Tenders
  • Training
    • In-Person Events
    • Webinars
  • Funding Opportunities
  • Working Party News
    • Working Party Archive
      • AMR Taskforce Archive
      • Covid 19 Taskforce Archive
      • Digital Working Party Archive
      • Environmental Working Party Archive
      • European Affairs Archive
      • Export Working Party Archive
      • External Affairs Working Party
      • Genomics Working Party Archive
      • Market Dynamics Archive
      • Near Patient Testing Working Party Archive
      • Regulatory Affairs Working Party Archive
      • Infectious Diseases Working Party Archive
      • Procurement Working Party Archive